Disclaimer: this data is provided for informational purposes only and should not be construed as investment or financial advice. Please consult with competent professionals when making investment decisions.
Private company investors are tightening up deals and lowering valuations for startups as “Unicorn Fever” begins to wear off.
The focus is back on lower middle-market software developers with Discover’s new fund.
Carlyle plans to buy back $200 million of shares amid lower than expected 4th quarter earnings.
Generic drugs are worth increased scrutiny from both investors and consumers.
Timmins Gold and Alexco rank among the top 5 TSX stocks.
Indian IT firm makes inroads into the U.S. insurance market by inking a deal with HealthPlan Services.
Stryker adds medical device manufacturer Synergetics to its roster as part of an overall acquisitions strategy.
Algonquin Power is also making inroads into U.S. markets with its acquisition of Empire District Electric.
Investors should keep their eyes peeled for opportunities in the health care industry with advances in nanotechnology that could treat cardiovascular disease and a cancer drug that may help prevent Alzheimer’s symptoms.
PE-backed Advance Disposal delays its IPO.
Web.com inks deal with online marketer Yodle.
This Day In History (Feb. 16): 1659: The first known cheque is issued for £400 and is now on display at Westminster Abbey.